Pramlintide is primarily used in the management of diabetes, particularly for patients with type 1 and type 2 diabetes who use mealtime insulin but still struggle to achieve optimal blood glucose control. It works by slowing down the rate at which food moves through the stomach, reducing the spike in blood sugar levels after meals. Additionally, pramlintide helps to suppress glucagon secretion, a hormone that raises blood sugar levels, and promotes a feeling of fullness, which can aid in weight management. This medication is administered via subcutaneous injection before meals and is often used in combination with insulin therapy to improve overall glycemic control. It is especially beneficial for patients who experience significant post-meal blood sugar fluctuations or have difficulty managing their weight despite insulin treatment.